Elsevier Biologicals April 2021
Can a fungal platform be faster and cheaper than other platforms, enabling many cheaper and quicker therapeutics? Joris Vandeputte responded that the ZAPI experience shows that the fungal C1 system is a high-performance system, which can produce high quantities of apparently excellent antigens, in the appropriate conformation, and well glycosylated, which has been confirmed in animal models. So, this is one of the platforms that should be further explored in the near future.